Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 24,484 - -
Change - -49.85% 49.53% -8.95% -16.56% 23.69% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 23,742 23,457 23,142
Change - -51.82% 51.78% -7.74% -18.07% 23.62% -1.2% -1.34%
P/E 54.1x 30.4x 44.7x 49x 40.5x 41.2x 36.1x 32.4x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 7.61x 6.68x 5.87x
PEG - -2.8x 23.04x -3.2x 27.09x 1.7x 2.6x 2.9x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.35x 6.92x 6.46x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.13x 6.63x 6.11x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 25.7x 23.1x 20.5x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 32x 28.5x 25.2x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 53.3x 45.7x 40.3x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.88% 2.19% 2.48%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.896 0.9681 1.137
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.26% 0.28% 0.33%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.42 9.606 10.68
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.6% 10.1% 10.6%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,331 3,538 3,789
EBITDA 1 884.7 882.6 827.9 728.2 793.8 923.1 1,018 1,131
EBIT 1 762.4 762 690.6 572.8 622.4 741.3 822.8 918.6
Net income 1 661.8 585.9 593.4 492.7 493.7 604.7 685.6 754.9
Net Debt 1 - -685.4 -647.1 -282 -588.5 -741.5 -1,026 -1,342
Reference price 2 469.01 235.35 352.12 327.56 275.14 346.56 346.56 346.56
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,648 - -
Announcement Date 2/17/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
41.16x7.13x25.72x0.26% 24.48B
23.45x3.46x13.01x2.73% 162B
18.38x3.2x11.28x3.68% 103B
15.78x0.18x11.32x0.83% 55.83B
33.02x8.02x20.98x1.22% 54.05B
37.72x3x10.31x2.54% 41.71B
36.16x1.33x11.73x0.22% 31.94B
28.05x4.99x15.91x-.--% 26.49B
23.17x3.39x12.19x1.25% 20.52B
23.66x3.02x12.32x1.37% 20.02B
Average 28.05x 3.77x 14.48x 1.41% 54.05B
Weighted average by Cap. 25.52x 3.59x 13.68x 2.05%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Valuation West Pharmaceutical Services, Inc.